Medicine Description letrozole 2.5mg
letrozole 2.5mg tablets is a medication classified as an aromatase inhibitor. It functions by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues. By reducing estrogen levels in the body, letrozole effectively limits the growth of estrogen-dependent tumors, particularly in hormone receptor-positive breast cancers. The decreased estrogen production helps to slow or halt the progression of cancer, making it a valuable treatment option for patients with specific breast cancer types.
Indications and Uses of letrozole 2.5mg tablets
- Treatment of hormone receptor-positive breast cancer in postmenopausal women.
- Adjuvant therapy to reduce the risk of recurrence in early-stage breast cancer.
- Treatment of advanced breast cancer following tamoxifen therapy.
- Off-label use in certain cases of infertility in women with polycystic ovary syndrome.
Side Effects of letrozole 2.5mg tablets
- Hot flashes.
- Joint pain or stiffness.
- Fatigue.
- Nausea.
- Increased sweating.
- Headaches.
- Bone thinning (osteoporosis).
Storage and Handling
Store letrozole 2.5mg tablets at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
Patient Advice and Precautions
Patients should be counseled to report any unusual side effects or symptoms to their healthcare provider. Regular monitoring for bone density is recommended due to the risk of osteoporosis. It is essential to maintain follow-up appointments to assess the effectiveness of the treatment and make any necessary adjustments. Avoid taking letrozole if pregnant or breastfeeding, and discuss all current medications with the healthcare provider to prevent potential interactions.